Zomato IPO: While the excitement among investor community has been thrilling, many experts have said that the valuations of the issue are on the higher side. Post navigation Bharat Biotech#39;s partner Ocugen seeks approval for Covaxin in Canada Zomato will be a long-term compounding story instead of multibagger one: Vinit Bolinjkar of Ventura Securities